FGF23 is normally expressed at considerably low levels in osteocytes but its expression is considered to be increased in patients with hypophosphatemic rickets (Liu et al., 2006; Endo et al., 2008) and in patients with chronic kidney disease (Pereira et al., 2009). This evidence concerns the gene FGF23 and Dent disease.